# Substance Balance Study of [14C]ZX-7101A in Healthy Adult Male Subjects in China

> **NCT05720091** · PHASE1 · COMPLETED · sponsor: **Nanjing Zenshine Pharmaceuticals** · enrollment: 6 (actual)

## Conditions studied

- Influenza, Human

## Interventions

- **DRUG:** ZX-7101A 80mg

## Key facts

- **NCT ID:** NCT05720091
- **Lead sponsor:** Nanjing Zenshine Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-14
- **Primary completion:** 2023-03-20
- **Final completion:** 2023-07-25
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2024-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05720091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05720091, "Substance Balance Study of [14C]ZX-7101A in Healthy Adult Male Subjects in China". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05720091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*